Do you support early-stage companies as well as established manufacturers?

XGene’s service scope is relevant to both development-stage sponsors and established pharmaceutical or life-sciences organizations. Early-stage companies may need help building an IND-ready CMC roadmap, identifying Module 3 gaps, defining control-strategy evidence, preparing for CDMO transfer, or establishing scalable quality practices. Established manufacturers may need targeted remediation, data-integrity assessment, inspection-response support, batch-record review, supplier oversight, or quality-system improvement. The exact engagement should be defined around product stage, regulatory pathway, internal capability, risk, and the decision the client needs to make.